Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HARRY L GREENBERG

Allopathic & Osteopathic Physicians Dermatology

NPI
1447276175
CMS profile
65174
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$197,192.59

420 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 9; records 51–100 of 420 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HARRY L GREENBERG

NPI 1447276175 · CMS profile ID 65174

Allopathic & Osteopathic Physicians / Dermatology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 9; records 51–100 of 420 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447276175?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HARRY L GREENBERG, NPI 1447276175, CMS profile ID 65174. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 420 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447276175?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). HARRY L GREENBERG, NPI 1447276175, CMS profile ID 65174. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 420 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447276175?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
HARRY L GREENBERG, NPI 1447276175, CMS profile ID 65174, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 420 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1447276175?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

420 matching records · $197,192.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 420 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 420.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $148.9211/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351409 CMS
Janssen Biotech, Inc. $315.2711/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351453 CMS
Janssen Biotech, Inc. $269.9011/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351463 CMS
Arcutis Biotherapeutics, Inc. $328.9011/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044721707 CMS
Arcutis Biotherapeutics, Inc. $315.2711/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044722161 CMS
GENZYME CORPORATION $16.4711/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049928127 CMS
Regeneron Healthcare Solutions, Inc. $3,843.0011/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999194157 CMS
Janssen Biotech, Inc. $31.1811/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351637 CMS
Lilly USA, LLC $22.3611/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031571861 CMS
ABBVIE INC. $124.9911/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384589 CMS
GENZYME CORPORATION $10.5711/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049928107 CMS
ABBVIE INC. $2.5111/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384587 CMS
ABBVIE INC. $3.5911/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384585 CMS
Regeneron Healthcare Solutions, Inc. $28.6911/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999194153 CMS
Galderma Laboratories, L.P. $6.2911/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059698885 CMS
Incyte Corporation $18.4911/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044783117 CMS
Janssen Biotech, Inc. $20.1311/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351585 CMS
ABBVIE INC. $2,400.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384583 CMS
LEO Pharma Inc. $25.0011/06/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053476819 CMS
Amgen Inc. $5.3811/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020586525 CMS
Dermavant Sciences, Inc. $6.6111/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991193501 CMS
Dermavant Sciences, Inc. $82.0011/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991193505 CMS
Incyte Corporation $5.9611/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044783165 CMS
ABBVIE INC. $20.3411/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384581 CMS
Arcutis Biotherapeutics, Inc. $4.8511/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044722075 CMS
Incyte Corporation $1,650.0011/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044783043 CMS
Incyte Corporation $4,675.0011/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044783093 CMS
Janssen Biotech, Inc. $13.9511/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351553 CMS
UCB, Inc. $27.7011/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021579111 CMS
GENZYME CORPORATION $9.2910/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049928139 CMS
Janssen Biotech, Inc. $13.2410/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351543 CMS
Amgen Inc. $21.9610/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020818021 CMS
Amgen Inc. $27.5110/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020818025 CMS
Amgen Inc. $32.8910/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020818033 CMS
Dermavant Sciences, Inc. $6.8210/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991193497 CMS
LEO Pharma Inc. $2,400.0010/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053476813 CMS
Novartis Pharmaceuticals Corporation $19.9010/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992346013 CMS
UCB, Inc. $22.4210/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021579099 CMS
GENZYME CORPORATION $17.4710/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049928051 CMS
Dermavant Sciences, Inc. $11.2210/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991193493 CMS
ABBVIE INC. $19.7010/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997384579 CMS
Arcutis Biotherapeutics, Inc. $17.0310/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044721955 CMS
Arcutis Biotherapeutics, Inc. $4,500.0010/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044721979 CMS
Novartis Pharmaceuticals Corporation $24.7510/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992345997 CMS
Galderma Laboratories, L.P. $40.9310/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059698883 CMS
Sun Pharmaceutical Industries Inc. $8.0410/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053856555 CMS
Janssen Biotech, Inc. $14.9210/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351607 CMS
Janssen Biotech, Inc. $3,713.0010/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054499 CMS
Arcutis Biotherapeutics, Inc. $14.5210/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044722087 CMS
Janssen Biotech, Inc. $19.1010/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351595 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $104,713.98 380
PY2020 $44,315.92 206
PY2021 $95,185.94 277
PY2022 $130,794.19 345
PY2023 $197,192.59 420
PY2024 $257,255.50 473
PY2025 $279,501.86 466

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,085.68 1
PY2025 Principal investigator $32,393.55 9
PY2024 Recipient $104.58 1
PY2024 Principal investigator $18,134.35 9
PY2023 Principal investigator $12,980.00 6
PY2022 Principal investigator $2,042.90 2
PY2021 Recipient $8,037.00 2
PY2021 Principal investigator $153,421.89 9
PY2020 Recipient $1,120.80 1
PY2020 Principal investigator $192,758.77 22
PY2019 Principal investigator $264.64 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $398.75 12/22/2025 Non-covered Recipient Entity
H L GREENBERG MD LTD
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184279634
Principal investigator 1 SANOFI US SERVICES INC. $889.65 10/17/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226090063
Principal investigator 1 Eli Lilly and Company $234.50 07/28/2025 Non-covered Recipient Entity
LAS VEGAS DERMATOLOGY
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187885956
Principal investigator 1 SANOFI US SERVICES INC. $1,696.95 07/11/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226090057
Principal investigator 1 SANOFI US SERVICES INC. $140.40 05/16/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226090009
Principal investigator 1 SANOFI US SERVICES INC. $807.30 04/11/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226090015
Recipient Eli Lilly and Company $1,085.68 04/03/2025 Covered Recipient Physician EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187873453
Principal investigator 1 Eli Lilly and Company $25,499.00 03/11/2025 Non-covered Recipient Entity
LAS VEGAS DERMATOLOGY
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187885954
Principal investigator 1 SANOFI US SERVICES INC. $140.40 01/29/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226089981
Principal investigator 1 SANOFI US SERVICES INC. $2,586.60 01/17/2025 Non-covered Recipient Entity
Las Vegas Dermatology Pc
Registry to characterize the patients who receive Dupixent for PN in a real-world setting No dispute reported 06/30/2026 1226089986